HIGHLIGHTS
- who: Hanan Babeker and collaborators from the Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S N , Canada have published the research: Engineering of a Fully Human Anti-MUC-16 Antibody and Evaluation as a PET Imaging Agent, in the Journal: Pharmaceutics 2022, 2824 of /2022/
- what: The authors seek to develop radiopharmaceuticals targeting the overexpression of biomarker, MUC16 (CA125), which is commonly overexpressed in ~80% of EOC and ~65% of PDAC. The authors report for the first time the development of a fully human monoclonal anti-MUC16 antibody . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.